| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fab40b1deb4264fab0e378e2bfe380e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2310-00329
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-30011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-30032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-3092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-30965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-56 |
| filingDate |
2010-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a287f6411e652881661eac93e35653ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88183f5b37a8828cce47291f0f89a545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd07438e38f0124f8601dc41185ccfad |
| publicationDate |
2012-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2493424-A1 |
| titleOfInvention |
Bone graft material |
| abstract |
The present disclosure relates to a bone graft material and a bone graft implant formed from the material. In some embodiments, the bone graft implant comprises a porous matrix having a plurality of overlapping and interlocking bioactive glass fibers and a plurality of pores dispersed throughout the matrix, whereby the fibers are characterized by fiber diameters ranging from about 5 nanometers to about 100 micrometers, and the pores are characterized by pore diameters ranging from about 100 nanometers to about 1 millimeter. The implant may be formed into a desired shape for a clinical application. The embodiments may be employed to treat a bone defect. For example, the bone graft material may be wetted and molded into a suitable form for implantation. The implant may then be introduced into a prepared anatomical site. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2565743-C2 |
| priorityDate |
2009-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |